| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 222.6 | 197.1 |
| Gross profit | 43.0 | 36.9 |
| Profit before tax | 21.6 | 22.9 |
| Net income | 11.0 | 13.1 |
| EPS (diluted, $ a share) | $-1.04 | $0.48 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -15.9% |
|---|---|
| Revenue, year on year | +12.9% |
| Gross margin | 19.3% |
| Operating margin | 11.3% |
10-Q filed with the SEC, NYSE: USPH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
U S Physical Therapy Inc: key numbers
- Share price
- $99.55Close, Nov 16
- Market cap
- $1.49B
- Shares outstanding
- 14.93MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Health ServicesSIC 8000
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from U S Physical Therapy Inc
All →U S Physical Therapy Financial Results
U.S. Physical Therapy hosted an earnings call to discuss its financial results for the third quarter and nine months ended September 30, 2026. The company reported record volume with 27 consecutive months of record visits and successfully transitioned its Metro New York facilities into the NYU Langone hospital partnership.
- Term
- Q3 2026
“With respect to visits, every month this year has been a record for that month. We are up to 27 consecutive months where that has occurred, nearly 2.5 years of record volume each and every month.”
Chris Reading, Chairman and CEO
U S Physical Therapy Financial Results
U.S. Physical Therapy, Inc. reported its financial results for the period ended September 30, 2026. The filing was made under Item 2.02, which is the standard SEC disclosure for quarterly or annual results of operations and financial condition.
U S Physical Therapy $171M Debt Financing with Bank of America, National Association
U.S. Physical Therapy, Inc. entered into a 45-month forward-starting interest rate swap agreement with Bank of America with an initial notional amount of $170.6 million. The swap fixes the variable interest rate on the company's existing term debt at 4.578% per annum effective June 30, 2027, through April 14, 2031. This transaction is designed to hedge interest rate risk associated with the company's Fourth Amended and Restated Credit Agreement.
- Value
- $171M
- Counterparty
- Bank of America, National Association
- Term
- 45 months
U S Physical Therapy Leadership Change
U.S. Physical Therapy, Inc. has appointed Myra Davis to its Board of Directors, effective October 1, 2026. Ms. Davis currently serves as the Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital and brings over two decades of healthcare technology leadership experience to the board.
- Counterparty
- Myra Davis